Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xilio Therapeutics (XLO) Prepaid Assets (2024 - 2025)

Xilio Therapeutics' Prepaid Assets history spans 2 years, with the latest figure at $2.8 million for Q3 2025.

  • For Q3 2025, Prepaid Assets rose 37.8% year-over-year to $2.8 million; the TTM value through Sep 2025 reached $2.8 million, up 37.8%, while the annual FY2024 figure was $4.9 million, N/A changed from the prior year.
  • Prepaid Assets for Q3 2025 was $2.8 million at Xilio Therapeutics, up from $2.2 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $5.2 million in Q1 2024 and bottomed at $2.0 million in Q3 2024.